Clinical Trial

A Study of MI226 Injection for Abdominal Fat Accumulation

Name: A Study of MI226 Injection for Abdominal Fat Accumulation — clinical trial record (NCT07749742)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

This is a Phase 1, randomized, double-blind (with open-label sentinel cohorts), placebo-controlled, single-ascending-dose study designed to evaluate the safety, tolerability, and pharmacokinetics (PK) of MI226 Injection in participants with abdominal fat accumulation.

Trial Details

NCT Number	NCT07749742
Lead Sponsor	Nanjing Minova Pharmaceutical Co., Ltd.
Conditions	Abdominal Fat
Enrollment	52 participants
Start Date	2026-07-28
Primary Completion	2027-02 (estimated)
Study Completion	2027-03 (estimated)
Updated on ClinicalTrials.gov	2026-08-06